With over 430 peer-reviewed publications and 32,025 citations, an H-INDEX is 99, she is an internationally renowned leader in cancer survivorship and outcomes research and has been continually funded by the NIH and by the Leukemia Lymphoma Society since 2000. She has also received funding from the Dept. of Defense, St. Baldrick’s Foundation, V Foundation and ASCO. Dr. Bhatia continues to serve on several Study Sections for the NCI. She serves on the scientific advisory board for several cancer centers as well as several T32 Training grants. She is Associate Editor for the Journal of Clinical Oncology and Senior Editor for CEBP. She is a past scholar of the Leukemia Lymphoma Society. She was elected to membership to the American Society for Clinical Investigation and to the Association of American Physicians. She is the recipient of the Frank H Oski Lectureship Award from the American Society of Pediatric Hematology Oncology. She received the Outstanding Investigator Award from the NCI. She has served on the Pediatric Cancer Working Group for the NCI Cancer “Moonshot” initiative and is currently serving on the the National Cancer Policy Forum, and the NCI Clinical Trials Advisory Committee. As director of the Institute for Cancer Outcomes and Survivorship, she has recruited 17 faculty members over the past 8 years, with varied clinical backgrounds (pediatric and adult hematology/oncology, surgical oncology, radiation oncology, nursing, neuropsychology, and molecular biology) but with a common research theme (cancer outcomes) to the Institute and has developed the necessary infrastructure to ensure that they succeed. She is passionate about mentoring junior investigators.